Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients

BACKGROUND: Malaria remains one of the most important infectious diseases. Treatment options for severe malaria are limited and the choline analogue SAR97276A is a novel chemical entity that was developed primarily as treatment for severe malaria. Before starting clinical investigations in severely...

Descripción completa

Detalles Bibliográficos
Autores principales: Held, Jana, Supan, Christian, Salazar, Carmen L. Ospina, Tinto, Halidou, Bonkian, Léa Nadège, Nahum, Alain, Sié, Ali, Abdulla, Salim, Cantalloube, Cathy, Djeriou, Elhadj, Bouyou-Akotet, Marielle, Ogutu, Bernhards, Mordmüller, Benjamin, Kreidenweiss, Andrea, Siribie, Mohamadou, Sirima, Sodiomon B., Kremsner, Peter G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418711/
https://www.ncbi.nlm.nih.gov/pubmed/28472957
http://dx.doi.org/10.1186/s12936-017-1832-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418711/
https://www.ncbi.nlm.nih.gov/pubmed/28472957
http://dx.doi.org/10.1186/s12936-017-1832-x

Ejemplares similares